Nafamostat reduces systemic inflammation in TLR7-mediated virus-like illness. (2022)

First Author: Yates AG
Attributed to:  University of Oxford Confidence in Concept Scheme – Round 4 funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1186/s12974-021-02357-y

PubMed Identifier: 34991643

Publication URI: http://europepmc.org/abstract/MED/34991643

Type: Journal Article/Review

Volume: 19

Parent Publication: Journal of neuroinflammation

Issue: 1

ISSN: 1742-2094